eanNews - Page 120 of 288 - Stay up to date with Neurology in Europe

- Executive Page: Multiple Opportunities to Serve & Support EAN & Neurology
  
  March 12, 2026
- President’s Corner – March 2026
  
  March 10, 2026
- Research Paper of the Month: Coffee and Tea Intake, Dementia Risk, and Cognitive Function
  
  March 2, 2026
- Executive Page: Building an Academic Path for Neurologists in Europe
  
  February 11, 2026
- President’s Corner – February 2026
  
  February 11, 2026
- Research Paper of the Month: Fremanezumab in Children and Adolescents with Episodic Migraine
  
  February 11, 2026

Top Articles

Calls for Coordinated Action on Brain Health in European Parliament on Brain Health Day

March 18, 2026

The European Parliament marked Brain Health Day: Prevention, Policy, Progress with a high‑level programme hosted by MEP Angelika Winzig, bringing renewed political attention to Europe’s urgent need for an integrated brain health strategy.

World’s largest brain research prize awarded for groundbreaking discoveries on how we sense touch and pain

March 6, 2026

12th Congress of the European Academy of Neurology celebrates with main headline that abstract submissions have hit record high!

EAN 2026 Hits New All-Time Abstract Submission Record

February 13, 2026

European Brain Health Summit 2026: Building the Foundation for a Brain-Healthy Society and Economy

February 12, 2026

Brain Health Day in white text on a blue-green gradient background

Join us for Brain Health Day: Prevention, Policy, Progress

February 11, 2026

Latest Posts

Breaking news EAN News COVID-19 Research
Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study

January 5, 2021

Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study
Breaking news EAN News COVID-19 Research
The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts

January 5, 2021

The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts
Breaking news EAN News COVID-19 Research
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

January 5, 2021

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Breaking news EAN News COVID-19 Research
Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study

January 5, 2021

Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
Breaking news EAN News COVID-19 Research
Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis

January 5, 2021

Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis
Breaking news EAN News COVID-19 Research
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

January 5, 2021

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Breaking news EAN News COVID-19 Research
Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19

January 5, 2021

Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19
Breaking news EAN News COVID-19 Research
Efficacy of Tocilizumab in Patients Hospitalized with COVID-19

January 5, 2021

Efficacy of Tocilizumab in Patients Hospitalized with COVID-19
Breaking news EAN News COVID-19 Research
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19

January 5, 2021

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19
Breaking news EAN News COVID-19 Research
A Neutralizing Monoclonal Antibody for Hospitalized Patients with COVID-19

January 5, 2021

A Neutralizing Monoclonal Antibody for Hospitalized Patients with COVID-19
Breaking news EAN News COVID-19 Research
Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

January 5, 2021

Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine
Executive Page EAN News Featured Slider
Executive Page: Happy New Year 2021 from the EAN, the Home of Neurology

January 4, 2021

Happy New Year 2021 from the EAN, the Home of Neurology
Paper of the Month EAN News COVID-19
COVID-19 Paper of the month: Neuropathology of patients with COVID-19 in Germany: a post-mortem case series

January 1, 2021

For January 2021, we have selected: Matschke et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 2020; 19:919-929. doi: 10.1016/S1474-4422(20)30308-2.
News in general Other News
Joint strategy sets direction for EMA and EU medicines regulatory agencies to 2025

January 1, 2021

EMA and the Heads of Medicines Agencies (HMA) have published their joint strategy for the next five years, following its recent adoption by the HMA and EMA Management Board.
News from EAN member societies Other News
2020 – BioMed Alliance celebrates 10 years of existence

January 1, 2021

2020 - BioMed Alliance celebrates 10 years of existence

Newer Posts

Older Posts